      Document 0012
 DOCN  DRG0012
 UNIQUE IDENTIFIER        DRG-0235
 NAME OF SUBSTANCE        Lobucavir [USAN 1996]
 REGISTRY NUMBER          127759-89-1
 STANDARD CHEMICAL NAME   6H-Purin-6-one-2-amino-9-(2,3-bis(hydroxymeth-
                          yl)- cyclobutyl)-1,9-dihyro-, (1R-(1alpha,
                          2beta, 3alpha))- [USAN 1996]
 SYNONYMS                 Carbocyclic oxetanocin-G [FDA 248A]
 SYNONYMS                 Cyclobut-G [FDA 248A]
 PROTOCOL ID NUMBERS      FDA 248A
 SECONDARY SOURCE ID      BMS-180194 [USAN 1996]
 SECONDARY SOURCE ID      SQ 34,514 [USAN 1996]
 DISEASES STUDIED/TREATED Cytomegalovirus (CMV) infections; HIV
                          infection [FDA 248A]
 CLASSIFICATION CODE      Antiviral [USAN 1996]
 CHEMICAL/PHYSICAL DATA   MOLECULAR FORMULA: C11H15NO3 [USAN 1996]
 CHEMICAL/PHYSICAL DATA   MOLECULAR WEIGHT: 265.27 [USAN 1996]
 SUBSTANCE DELIVERY DATA  MODE OF DELIVERY: Oral. [FDA 248A]
 MANUFACTURERS            Bristol-Myers Squibb Company
 REFERENCES               Hayshi S, Norbeck DW, Rosenbrook W, Fine RL,
                          Matsukura M, Plattner JJ, Broder S, Mitsuya
                          H. Cyclobut-A and cyclobut-G, carbocyclic
                          oxetanocin analogs that inhibit the
                          replication of human immunodeficiency virus
                          in T cells and monocytes and macrophages in
                          vitro. Antimicrob Agents Chemother. 1990
                          Feb;34(2):287-94.
 ENTRY MONTH              9511
 LAST REVISION DATE       951129
 

SOURCE: National Library of Medicine, Bethesda, MD.  Distributed by AEGIS.
